Medications delivered by such a means include fentanyl transmucosal lozenges, sublingual nitroglycerin, and intranasal DDAVP, and have existed with great clinical success for many years.

Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...

New research is showing the potential of an intranasal vaccine that’s been in development for four years, and it’s not just good news for the needle-phobes out there. “This is a live ...

Objective: To characterize the pharmacokinetic-pharmacodynamic correlation of intranasal and intravenous fentanyl in opioid-naïve patients undergoing third molar extraction. Methods: A double ...

"This is a live attenuated intranasal vaccine, called CDO-7N-1, designed to be administered intranasally, thereby inducing potential mucosal immunity as well as systemic immunity with just a ...

A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic. New Griffith University research, "A ...

Regional Analysis: Gain insights into the U.S. market, estimated at $24.6 Billion in 2023, and China, forecasted to grow at an impressive 8.9% CAGR to reach $8.1 Billion by 2030. Discover growth ...

However, intramuscular vaccines fail to induce local mucosal immunity. Comparatively, intranasal vaccines stimulate local and systemic immune responses against respiratory pathogens. This prevents ...

Tonix Pharma receives US patent covering the intranasal delivery of Tosymra to treat migraine: Chatham, New Jersey Saturday, September 21, 2024, 13:00 Hrs [IST] Tonix Pharmaceutic ...

Alzheimer’s disease is the most common form of dementia, affecting more than 6 million people in the United States alone. Despite extensive research, effective treatments remain limited, and the need ...